Skip to content

Effect of sesame on metabolic syndrome

Effect of sesame seeds consumption on metabolic syndrome components, serum level of Angiotensin II and Adiponectin in women with metabolic syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014051814680N2
Enrollment
50
Registered
2014-06-10
Start date
2014-02-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome. Other metabolic disorders

Interventions

Intervention 1: Intervention Group: having healthy diet and daily 50 g sesame seed powder consumption for 6 weeks. Intervention 2: Control Group: having healthy diet.
Lifestyle
Control Group: having healthy diet
Intervention Group: having healthy diet and daily 50 g sesame seed powder consumption for 6 weeks

Sponsors

Vice Chancellor for research of Ahvaz Joundishapour University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: adult woman over 30 years old, subjects having 3 or more of the criteria for diagnosis of metabolic syndrome (waist circumference 80cm and more, triglycerides 150 mg/dl and more, High Density Lipoprotein Cholesterol 50mg/dl and more, fasting blood sugar 100 mg/dl and more , blood pressure 130/85mmHg and more.Exclusion criteria: history of alcohol abuse and drug dependence; hormonal therapy; acute or chronic inflammatory; history of cancer; use of multivitamin-mineral and antioxidant supplements 6 months prior to the study; a restrictive diet or weight change 5 kg and more during 3 months prior to study; pregnancy and lactating; and sesame allergy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Systolic and diastolic blood pressure. Timepoint: baseline and after 6 weeks. Method of measurement: Aneroid sphygmomanometer.;Fasting blood sugar. Timepoint: baseline and after 6 weeks. Method of measurement: Spectrophotometry.;Total Cholesterol. Timepoint: baseline and after 6 weeks. Method of measurement: Spectrophotometry.;Triglyceride. Timepoint: baseline and after 6 weeks. Method of measurement: Spectrophotometry.;Low Density Lipoprotein Cholesterol. Timepoint: baseline and after 6 weeks. Method of measurement: Friedewald Formula.;High Density Lipoprotein Cholesterol. Timepoint: baseline and after 6 weeks. Method of measurement: Spectrophotometry.;Waist circumference. Timepoint: baseline and after 6 weeks. Method of measurement: Midway between the lower rib margin and the iliac crest.;Angiotensin II. Timepoint: baseline and after 6 weeks. Method of measurement: ELIZA.;Adiponectin. Timepoint: baseline and after 6 weeks. Method of measurement: ELIZA.

Secondary

MeasureTime frame
Dietary Factors. Timepoint: during duration of study. Method of measurement: 3-day 24h dietary recalls.;Body Mass Index. Timepoint: Baseline and after 6 weeks. Method of measurement: Formula.;Insuline. Timepoint: Baseline and after 6 weeks. Method of measurement: ELIZA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNegar Hojati

Para medicine Faculty, Ahvaz Joundishapour University of Medical Science

negar_hojati@yahoo.com+98 61 1373 8319

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026